News & Events
-
January 31, 2017
Highlights from the 02 August CDISC Strategy Session
The CDISC Strategy Session highlight video includes an interview with Cheryl Fitzer-Attas (CHDI Foundation) discussing the importance of data standards to Huntington’s disease research and the new Huntington’s Disease Regulatory Science Consortium (HD-RSC), a collaboration between C-Path and CHDI.... -
January 31, 2017
Bring Your Own Device (BYOD)
This webinar provides an overview of scientific, logistical, and regulatory considerations when using a BYOD approach to collect patient-reported outcome data in clinical trials. Presenters: Jennifer Crager (YPrime) and Paul O’Donohoe, MS (CRF Health) PDF version... -
October 27, 2016
Ensuring Equivalence of Electronic and Paper Administration of Patient-Reported Outcome Measures
This webinar provides an overview of scientific and regulatory considerations when migrating paper-based patient-reported outcome (PRO) measures to electronic modes of data collection. Presenters: Paul O’Donohoe, MS (CRF Health) and Willie Muehlhausen, DVM (ICON)... -
October 27, 2016
Ensuring Equivalence of Electronic and Paper Administration of Patient-Reported Outcome Measures
This webinar provides an overview of scientific and regulatory considerations when migrating paper-based patient-reported outcome (PRO) measures to electronic modes of data collection. Presenters: Paul O’Donohoe, MS (CRF Health) and Willie Muehlhausen, DVM (ICON) PDF version... -
May 26, 2016 - July 14, 2016
Current trends in BSEP inhibition and perturbation to bile acid homeostasis as mechanisms of drug-induced liver injury
The Critical Path Institute’s Predictive Safety Testing Consortium hosted a webinar series focused on BSEP inhibition and perturbation to bile acid homeostasis as mechanisms of drug-induced liver injury. Over the course of six two-hour webinars, scientists presented current data and research on clinical examples of BSEP inhibition and hepatotoxicity, in vivo tools for confirming perturbation......